Moderator: 3ne2nr Mods
Only for a short time BUD.BUG wrote:BUG wrote:novastar1 wrote:pugboy wrote:yeah unless you can show u walking to grocery or parlornovastar1 wrote:So walking around outside alone is essentially illegal now?
Walking alone and not going anywhere would be safer than going to that grocery and parlor
So I should expect no cyclists on the road tomorrow either?
Why would there be no cyclists or people walking alone tomorrow from 5:00am to 9:00pm?
For anyone else unaware, all outdoor exercise has been banned 24/7.
https://newsday.co.tt/2021/05/16/outdoo ... nned-24-7/
So I can have 5 random people liming in my house but I can't ride my bike on the road by myself. Absolutely ridiculous. I'm speechless.
BUG wrote:BUG wrote:novastar1 wrote:pugboy wrote:yeah unless you can show u walking to grocery or parlornovastar1 wrote:So walking around outside alone is essentially illegal now?
Walking alone and not going anywhere would be safer than going to that grocery and parlor
So I should expect no cyclists on the road tomorrow either?
Why would there be no cyclists or people walking alone tomorrow from 5:00am to 9:00pm?
For anyone else unaware, all outdoor exercise has been banned 24/7.
https://newsday.co.tt/2021/05/16/outdoo ... nned-24-7/
So I can have 5 random people liming in my house but I can't ride my bike on the road by myself. Absolutely ridiculous. I'm speechless.
Zim wrote:Just lost a relative to this virus, her mom died abt a week prior
Dohplaydat wrote:BUG wrote:BUG wrote:novastar1 wrote:pugboy wrote:yeah unless you can show u walking to grocery or parlornovastar1 wrote:So walking around outside alone is essentially illegal now?
Walking alone and not going anywhere would be safer than going to that grocery and parlor
So I should expect no cyclists on the road tomorrow either?
Why would there be no cyclists or people walking alone tomorrow from 5:00am to 9:00pm?
For anyone else unaware, all outdoor exercise has been banned 24/7.
https://newsday.co.tt/2021/05/16/outdoo ... nned-24-7/
So I can have 5 random people liming in my house but I can't ride my bike on the road by myself. Absolutely ridiculous. I'm speechless.
Technically, you should be able to bike if it's your mode of transport.....just do wear track pants and thing so it won't look like exercise.
The same way they banned 'running' on the QP Savannah but technically walking on the sidewalk isn't illegal, so you can walk just not run.
Stupid.
wtf wrote:Who can confirm.Screenshot_20210516-221112_Facebook.jpeg
wtf wrote:Who can confirm.Screenshot_20210516-221112_Facebook.jpeg
home AFAIK. Cousin, well, more like aunty had asthmasMASH wrote:Zim wrote:Just lost a relative to this virus, her mom died abt a week prior
were they at home or in the system?
greetings, MP, thank u kindly, they are accepted. Much appreciated, mateMaxPower wrote:Zim wrote:Just lost a relative to this virus, her mom died abt a week prior
Hello Zim,
Please accept my condolences.
Please be safe out there.
shucks. at least they wasnt stick up under a tent. condolences to u and yours.Zim wrote:home AFAIK. Cousin, well, more like aunty had asthmasMASH wrote:Zim wrote:Just lost a relative to this virus, her mom died abt a week prior
were they at home or in the system?
Do some research one this OTC spray that's is already available to the public..redmanjp wrote:new treatment showing promise
https://www.clinicaltrialsarena.com/news/sanotize-nasal-spray-reduces-covid-19-viral-load-uk-clinical-trail/SaNOtize’s “revolutionary” Covid-19 nasal spray bolstered by Phase II trial data
By Kezia Parkins
16 Mar 2021 (Last Updated March 17th, 2021 10:39)
A self-administered nitric oxide nasal spray (NONS) made by Vancouver-based biotech firm SaNOtize has been found to dramatically reduce Covid-19 viral load in infected patients after completing early-stage clinical trials in Canada and, most recently, the UK.
SaNOtize’s “revolutionary” Covid-19 nasal spray bolstered by Phase II trial data
SaNOtize’s “revolutionary” Covid-19 nasal spray bolstered by UK Phase II trial data. Image Credit: Suttersock
Share Article
A self-administered nitric oxide nasal spray (NONS) made by Vancouver-based biotech firm SaNOtize has been found to dramatically reduce Covid-19 viral load in infected patients after completing early-stage clinical trials in Canada and, most recently, the UK.
SaNOtize, alongside Ashford and St Peter’s Hospitals NHS Foundation Trust and Berkshire and Surrey Pathology Services in the UK, have announced results of Phase II trials indicating that SaNOtize’s nasal spray represents a safe and powerful antiviral treatment that could prevent the transmission of Covid-19, shorten its duration, and reduce the severity of symptoms in those already infected.
In a randomised, double-blind, placebo-controlled Phase II trial that evaluated 79 confirmed cases of Covid-19, SaNOtize’s early treatment significantly decreased the level of SARS-CoV-2, including in patients with high viral loads infected by the concerning UK variant of Covid-19.
Patients treated with SaNOtize’s spray saw an average viral log reduction of 1.362 in the first 24 hours, which corresponds to a decline of around 95%. Within 72 hours the viral load plummeted by more than 99%. No adverse events were recorded in the UK trial nor in earlier Canadian trials that saw over 7,000 patients testing the self-administered treatment.
“I expect this to be a major advance in the global battle against the devastating human impacts of the Covid-19 pandemic,” said consultant medical virologist and chief investigator of the NHS trial Dr Stephen Winchester.
“This simple portable nasal spray could be highly effective in the treatment of Covid-19 and reducing onward transmission. Our trial included patients with a variant of concern and high viral loads yet still demonstrated significant reductions in the levels of SARS-CoV-2, which could be critical in supporting vaccines, preventing future outbreaks and safely reopening economies. Simply stated, I think this could be revolutionary.”
To date, NONS is the only novel therapeutic treatment outside of expensive monoclonal antibodies that has been proven to reduce SARS-CoV-2 viral load in humans, SaNOtize said.
The SaNOtize treatment kills the virus in the upper airways, preventing it from incubating and making its way to the lungs.
The therapy’s active ingredient is nitric oxide (NO), a natural nanomolecule produced by the human body with proven anti-microbial properties shown to have a direct effect on the –replication of SARS-CoV-2.
Covid-19 chart
THEMATIC REPORTS
Are you worried about the pace of innovation in your industry?
GlobalData's TMT Themes 2021 Report tells you everything you need to know about disruptive tech themes and which companies are best placed to help you digitally transform your business.
Find out more
Based on the trial results, SaNOtize is planning to submit emergency use applications to regulatory authorities in the UK and Canada for the treatment and prevention of Covid-19.
SaNOtize co-founder and chief scientific officer Dr Chris Miller told Clinical Trials Arena: “Appropriate manufacturing facilities and materials are in place or in progress in the countries where we are seeking approval, so a ramp-up in manufacturing would be a matter of weeks, and major scale-up in a very few months, once approvals have been received. It would be premature to speculate on a precise timeline, however.
“We are in talks with various manufacturers and potential partners but can’t comment on any talks with counter-parties that may be taking place. We are currently focused on the approval processes in the UK and Canada.”
The company said swift approval and accelerated manufacturing could expedite an almost immediate safe return to normal work, school and social life, and accelerate economic recovery when compared to relying on vaccines alone.
“Now that NONS has been demonstrated to be safe and effective in clinical trials, we must move with urgency to get it into the hands of the public where it can help bring an end to the pandemic, accelerate a return to normality, and prevent future outbreaks of Covid-19 and its variants,” said SaNOtize CEO and co-founder Dr Gilly Regev.
“The human toll of this disease cannot be expressed simply in numbers, and each day compounds the frustration, fear and loss suffered by millions around the world. Combined with the roll-out of vaccines, NONS can help get the world back on its feet.”
gastly369 wrote:Do some research one this OTC spray that's is already available to the public..redmanjp wrote:new treatment showing promise
https://www.clinicaltrialsarena.com/news/sanotize-nasal-spray-reduces-covid-19-viral-load-uk-clinical-trail/SaNOtize’s “revolutionary” Covid-19 nasal spray bolstered by Phase II trial data
By Kezia Parkins
16 Mar 2021 (Last Updated March 17th, 2021 10:39)
A self-administered nitric oxide nasal spray (NONS) made by Vancouver-based biotech firm SaNOtize has been found to dramatically reduce Covid-19 viral load in infected patients after completing early-stage clinical trials in Canada and, most recently, the UK.
SaNOtize’s “revolutionary” Covid-19 nasal spray bolstered by Phase II trial data
SaNOtize’s “revolutionary” Covid-19 nasal spray bolstered by UK Phase II trial data. Image Credit: Suttersock
Share Article
A self-administered nitric oxide nasal spray (NONS) made by Vancouver-based biotech firm SaNOtize has been found to dramatically reduce Covid-19 viral load in infected patients after completing early-stage clinical trials in Canada and, most recently, the UK.
SaNOtize, alongside Ashford and St Peter’s Hospitals NHS Foundation Trust and Berkshire and Surrey Pathology Services in the UK, have announced results of Phase II trials indicating that SaNOtize’s nasal spray represents a safe and powerful antiviral treatment that could prevent the transmission of Covid-19, shorten its duration, and reduce the severity of symptoms in those already infected.
In a randomised, double-blind, placebo-controlled Phase II trial that evaluated 79 confirmed cases of Covid-19, SaNOtize’s early treatment significantly decreased the level of SARS-CoV-2, including in patients with high viral loads infected by the concerning UK variant of Covid-19.
Patients treated with SaNOtize’s spray saw an average viral log reduction of 1.362 in the first 24 hours, which corresponds to a decline of around 95%. Within 72 hours the viral load plummeted by more than 99%. No adverse events were recorded in the UK trial nor in earlier Canadian trials that saw over 7,000 patients testing the self-administered treatment.
“I expect this to be a major advance in the global battle against the devastating human impacts of the Covid-19 pandemic,” said consultant medical virologist and chief investigator of the NHS trial Dr Stephen Winchester.
“This simple portable nasal spray could be highly effective in the treatment of Covid-19 and reducing onward transmission. Our trial included patients with a variant of concern and high viral loads yet still demonstrated significant reductions in the levels of SARS-CoV-2, which could be critical in supporting vaccines, preventing future outbreaks and safely reopening economies. Simply stated, I think this could be revolutionary.”
To date, NONS is the only novel therapeutic treatment outside of expensive monoclonal antibodies that has been proven to reduce SARS-CoV-2 viral load in humans, SaNOtize said.
The SaNOtize treatment kills the virus in the upper airways, preventing it from incubating and making its way to the lungs.
The therapy’s active ingredient is nitric oxide (NO), a natural nanomolecule produced by the human body with proven anti-microbial properties shown to have a direct effect on the –replication of SARS-CoV-2.
Covid-19 chart
THEMATIC REPORTS
Are you worried about the pace of innovation in your industry?
GlobalData's TMT Themes 2021 Report tells you everything you need to know about disruptive tech themes and which companies are best placed to help you digitally transform your business.
Find out more
Based on the trial results, SaNOtize is planning to submit emergency use applications to regulatory authorities in the UK and Canada for the treatment and prevention of Covid-19.
SaNOtize co-founder and chief scientific officer Dr Chris Miller told Clinical Trials Arena: “Appropriate manufacturing facilities and materials are in place or in progress in the countries where we are seeking approval, so a ramp-up in manufacturing would be a matter of weeks, and major scale-up in a very few months, once approvals have been received. It would be premature to speculate on a precise timeline, however.
“We are in talks with various manufacturers and potential partners but can’t comment on any talks with counter-parties that may be taking place. We are currently focused on the approval processes in the UK and Canada.”
The company said swift approval and accelerated manufacturing could expedite an almost immediate safe return to normal work, school and social life, and accelerate economic recovery when compared to relying on vaccines alone.
“Now that NONS has been demonstrated to be safe and effective in clinical trials, we must move with urgency to get it into the hands of the public where it can help bring an end to the pandemic, accelerate a return to normality, and prevent future outbreaks of Covid-19 and its variants,” said SaNOtize CEO and co-founder Dr Gilly Regev.
“The human toll of this disease cannot be expressed simply in numbers, and each day compounds the frustration, fear and loss suffered by millions around the world. Combined with the roll-out of vaccines, NONS can help get the world back on its feet.”
xlear nasal spray with xylitol
Do we have this in Trinidad or will have to purchased via skybox from amazon(its selling on amazon readily available)
https://www.medicaldevice-network.com/uncategorised/coronavirus-company-news-summary-us-fda-authorises-letsgetcheckeds-home-collection-covid-19-test-xlear-submits-covid-19-pre-emergency-use-authorisation-to-fda-for-nasal-spray/
https://www.biospace.com/article/more-data-suggests-over-the-counter-nasal-spray-is-effective-against-covid-19-virus/
Same applies to Habit7The_Honourable wrote:Braveboy is not a credible source, spreads exaggerated and fake news.
bluefete wrote:Now hearing a Std.5 teacher from Grant Memorial passed away.
Anyone can confirm?
JUST IN LOTTO SHUTDOWN
CHAIRMAN OF THE NLCB BOARD EUSTACE NANCIS, HAS CONFIRMED, THE SHUTDOWN/ SUSPENSION OF ALL LOTTO MACHINES IN THE COUNTRY, UNTIL FURTHER NOTICE.
A PHOTO OF WHAT LOTTO AGENTS SAW ON THEIR SCREENS THIS MORNING, HAS BEEN ADDED TO THIS POST.
Liz Williams.
Wonder if can come in thru skybox.. Gonna msg them n seetimelapse wrote:Too lazy to scroll back to quote Redman, but all respect due bro.
I have been taking L-Arginine supplements since last year once I saw how the symptoms of covid worked.It essentially converts into Nitric oxide.Very beneficial to your cardiovascular system .I am personally seeing a lot of improvement in my circulation and energy level.
Apart from the occasional Sahara dust congestion, I believe it has improved my breathing too.Not saying it can cure Covid or anything like that, but definitely a good product .gastly369 wrote:Do some research one this OTC spray that's is already available to the public..redmanjp wrote:new treatment showing promise
https://www.clinicaltrialsarena.com/news/sanotize-nasal-spray-reduces-covid-19-viral-load-uk-clinical-trail/SaNOtize’s “revolutionary” Covid-19 nasal spray bolstered by Phase II trial data
By Kezia Parkins
16 Mar 2021 (Last Updated March 17th, 2021 10:39)
A self-administered nitric oxide nasal spray (NONS) made by Vancouver-based biotech firm SaNOtize has been found to dramatically reduce Covid-19 viral load in infected patients after completing early-stage clinical trials in Canada and, most recently, the UK.
SaNOtize’s “revolutionary” Covid-19 nasal spray bolstered by Phase II trial data
SaNOtize’s “revolutionary” Covid-19 nasal spray bolstered by UK Phase II trial data. Image Credit: Suttersock
Share Article
A self-administered nitric oxide nasal spray (NONS) made by Vancouver-based biotech firm SaNOtize has been found to dramatically reduce Covid-19 viral load in infected patients after completing early-stage clinical trials in Canada and, most recently, the UK.
SaNOtize, alongside Ashford and St Peter’s Hospitals NHS Foundation Trust and Berkshire and Surrey Pathology Services in the UK, have announced results of Phase II trials indicating that SaNOtize’s nasal spray represents a safe and powerful antiviral treatment that could prevent the transmission of Covid-19, shorten its duration, and reduce the severity of symptoms in those already infected.
In a randomised, double-blind, placebo-controlled Phase II trial that evaluated 79 confirmed cases of Covid-19, SaNOtize’s early treatment significantly decreased the level of SARS-CoV-2, including in patients with high viral loads infected by the concerning UK variant of Covid-19.
Patients treated with SaNOtize’s spray saw an average viral log reduction of 1.362 in the first 24 hours, which corresponds to a decline of around 95%. Within 72 hours the viral load plummeted by more than 99%. No adverse events were recorded in the UK trial nor in earlier Canadian trials that saw over 7,000 patients testing the self-administered treatment.
“I expect this to be a major advance in the global battle against the devastating human impacts of the Covid-19 pandemic,” said consultant medical virologist and chief investigator of the NHS trial Dr Stephen Winchester.
“This simple portable nasal spray could be highly effective in the treatment of Covid-19 and reducing onward transmission. Our trial included patients with a variant of concern and high viral loads yet still demonstrated significant reductions in the levels of SARS-CoV-2, which could be critical in supporting vaccines, preventing future outbreaks and safely reopening economies. Simply stated, I think this could be revolutionary.”
To date, NONS is the only novel therapeutic treatment outside of expensive monoclonal antibodies that has been proven to reduce SARS-CoV-2 viral load in humans, SaNOtize said.
The SaNOtize treatment kills the virus in the upper airways, preventing it from incubating and making its way to the lungs.
The therapy’s active ingredient is nitric oxide (NO), a natural nanomolecule produced by the human body with proven anti-microbial properties shown to have a direct effect on the –replication of SARS-CoV-2.
Covid-19 chart
THEMATIC REPORTS
Are you worried about the pace of innovation in your industry?
GlobalData's TMT Themes 2021 Report tells you everything you need to know about disruptive tech themes and which companies are best placed to help you digitally transform your business.
Find out more
Based on the trial results, SaNOtize is planning to submit emergency use applications to regulatory authorities in the UK and Canada for the treatment and prevention of Covid-19.
SaNOtize co-founder and chief scientific officer Dr Chris Miller told Clinical Trials Arena: “Appropriate manufacturing facilities and materials are in place or in progress in the countries where we are seeking approval, so a ramp-up in manufacturing would be a matter of weeks, and major scale-up in a very few months, once approvals have been received. It would be premature to speculate on a precise timeline, however.
“We are in talks with various manufacturers and potential partners but can’t comment on any talks with counter-parties that may be taking place. We are currently focused on the approval processes in the UK and Canada.”
The company said swift approval and accelerated manufacturing could expedite an almost immediate safe return to normal work, school and social life, and accelerate economic recovery when compared to relying on vaccines alone.
“Now that NONS has been demonstrated to be safe and effective in clinical trials, we must move with urgency to get it into the hands of the public where it can help bring an end to the pandemic, accelerate a return to normality, and prevent future outbreaks of Covid-19 and its variants,” said SaNOtize CEO and co-founder Dr Gilly Regev.
“The human toll of this disease cannot be expressed simply in numbers, and each day compounds the frustration, fear and loss suffered by millions around the world. Combined with the roll-out of vaccines, NONS can help get the world back on its feet.”
xlear nasal spray with xylitol
Do we have this in Trinidad or will have to purchased via skybox from amazon(its selling on amazon readily available)
https://www.medicaldevice-network.com/uncategorised/coronavirus-company-news-summary-us-fda-authorises-letsgetcheckeds-home-collection-covid-19-test-xlear-submits-covid-19-pre-emergency-use-authorisation-to-fda-for-nasal-spray/
https://www.biospace.com/article/more-data-suggests-over-the-counter-nasal-spray-is-effective-against-covid-19-virus/
aaron17 wrote:Got this from facebook
KM_2NR wrote:It took a SOE for Trini's to get with the program , if they can't listen they will feel as my dad would say. Was a fun lil drive to PoS , my job make me waste my time by coming to work , I gone. I sure other employers want staff to come out but according to legal notice 142 of 2021 a lot of people not supposed to be out and by the amount of cars I saw this morning people still coming out . Be safe y'all
CoolMaxPower wrote:aaron17 wrote:Got this from facebook
Hello aaron17,
Thank you for the screenshot.
Well said by Danny.